Instem Reports a Strong H1 2022

Proactive interview with Phil Reason,
Instem CEO

Investor Meet Company: Results and Company Update
September 2022

Presentation now available to watch on-demand

Watch Now

A global provider of leading software solutions
and services to the life sciences community.

Helping our clients bring life enhancing products to market faster.

Learn more

Creating a more connected ecosystem in the
life sciences industry by consolidating and
harmonizing a fragmented IT marketplace.

Learn more

Welcome to the Instem Investor Centre

Instem (AIM:INS.L) is a leading provider of IT solutions and services to the global early development healthcare market, delivering compelling solutions for data collection, analysis and regulatory submissions management.


Latest News

27 September 2022 - Half Year Report

Read More

27 September 2022 - Settlement of Historical Contractual Licence Dispute

Read More

13 September 2022 - Notice of Results and Investor Presentation

Read More

Annual Report 2021

Another positive period for Instem

Annual Report 2021

Our achievements and performance in 2021 have been exceptional and we have accomplished a fundamental strategic shift in scale and reach having completed three important acquisitions.

Another positive period for Instem

Research Note by Gareth Evans of Progressive Equity Research